Revolution Medicines, Inc. (NASDAQ: RVMD) reported Q2 EPS of ($0.81), $0.04 worse than the analyst estimate of ($0.77).

For earnings history and earnings-related data on Revolution Medicines, Inc. (RVMD) click here.